All Blogs

Jan 23, 2023

Uncomplicated UTI Treatment: Challenges and Opportunities in the Market


Jan 18, 2023

How Are Innovations in Drug Delivery Devices Solving the Complex Challenges in the Market?


Jan 20, 2023

Post-traumatic Stress Disorder (PTSD) Treatment: Will the Emerging Therapies Succeed in Curing this Invisible Wound?


Jan 17, 2023

FDA Approves Luye’s Rykindo; EU Approves AstraZeneca’s Tezspire; Oramed Announces Trial Results of ORMD-0801; Eisai and Biogen File Lecanemab in the EU; AbbVie and Anima Biotech Announce Collaboration; AstraZeneca’s Avillion Receives FDA Approval


Jan 16, 2023

New Technologies Conquering Drug Delivery Obstacles in Acute Ocular Pain Treatment Landscape


Jan 13, 2023

Off-label Therapies Dominating the Behcet’s Syndrome Treatment Market


Jan 12, 2023

Vivos Therapeutics ‘s DNA Oral Appliance for the Treatment of OSA; Arthrex’s TightRope Implant for Pediatric ACL Surgery; Chindex Medical Acquired 10 ViewRay MRIdian Systems; Zimmer Biomet to Acquire Embody; GE HealthCare to buy IMACTIS; Glaukos Announced the iDose TR Exchange Trial


Jan 11, 2023

Digital Health: Insights Into the Key Transformative Trends & Evolving Market Dynamics


Jan 10, 2023

Ipsen to Acquire Albireo; Chiesi Farmaceutici to Buy Amryt Pharma; Takeda Presents Phase III Results of TAK-755 for cTTP; ACELYRIN Acquires ValenzaBio; FDA Approves LEQEMBI for Alzheimer’s Disease; Orphan Drug Designation to Lantern Pharma’s LP-284 for MLL


Jan 09, 2023

Is it the Dawn of Biologics in the Eosinophilic Esophagitis Treatment Landscape?